Fidelity Investments’s Q32 Bio QTTB Stock Holding History

Fidelity Investments’s Portfolio QTTB Stock Details QTTB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$21.8K	Buy	3,400 +36	+1%	+$171	﹤0.01%	4476
2025 Q4	$11.2K	Sell	3,364 -12,503	-79%	-$35.3K	﹤0.01%	4690
2025 Q3	$31.4K	Sell	15,867 -26,572	-63%	-$51.1K	﹤0.01%	4172
2025 Q2	$63.2K	Sell	42,439 -19,952	-32%	-$34K	﹤0.01%	3788
2025 Q1	$103K	Buy	62,391 +13,211	+27%	+$35.6K	﹤0.01%	3541
2024 Q4	$169K	Sell	49,180 -377,122	-88%	-$11.9M	﹤0.01%	3335
2024 Q3	$19M	Buy	426,302 +246,664	+137%	+$9.06M	﹤0.01%	1724
2024 Q2	$3.22M	Buy	179,638 +176,125	+5,014%	+$4.21M	﹤0.01%	2207
2024 Q1	$59.9K	Sell	3,513 -171	-5%	-$2.36K	﹤0.01%	3495
2023 Q4	$40.3K	Buy	3,684 +156	+4%	+$2.28K	﹤0.01%	3610
2023 Q3	$74.3K	Sell	3,528 -140	-4%	-$2.85K	﹤0.01%	3207
2023 Q2	$58.4K	Sell	3,668 -467	-11%	-$8.38K	﹤0.01%	3369
2023 Q1	$76.7K	Buy	4,135 +604	+17%	+$15K	﹤0.01%	3286
2022 Q4	$80.1K	Sell	3,531 -14,455	-80%	-$384K	﹤0.01%	3285
2022 Q3	$521K	Sell	17,986 -21,792	-55%	-$889K	﹤0.01%	2768
2022 Q2	$1.41M	Sell	39,778 -7,802	-16%	-$266K	﹤0.01%	2591
2022 Q1	$2.6M	Sell	47,580 -22,036	-32%	-$1.37M	﹤0.01%	2540
2021 Q4	$4.56M	Hold	69,616	–	–	﹤0.01%	2389
2021 Q3	$9.86M	Hold	69,616	–	–	﹤0.01%	2130
2021 Q2	$9.11M	Buy	69,616 +41,671	+149%	+$5.2M	﹤0.01%	2149
2021 Q1	$4.73M	Sell	27,945 -23,739	-46%	-$5M	﹤0.01%	2271
2020 Q4	$10.5M	Sell	51,684 -46,539	-47%	-$9M	﹤0.01%	1956
2020 Q3	$18.9M	Sell	98,223 -25,861	-21%	-$5.8M	﹤0.01%	1588
2020 Q2	$33.9M	Buy	124,084 +1,733	+1%	+$462K	﹤0.01%	1321
2020 Q1	$34.2M	Buy	122,351 +1,935	+2%	+$593K	﹤0.01%	1178
2019 Q4	$44.9M	Buy	120,416 +2,357	+2%	+$675K	0.01%	1249
2019 Q3	$38.5M	Sell	118,059 -1,521	-1%	-$517K	﹤0.01%	1299
2019 Q2	$42.1M	Buy	119,580 +2,349	+2%	+$923K	﹤0.01%	1309
2019 Q1	$58.5M	Sell	117,231 -33	-0%	-$14.8K	0.01%	1150
2018 Q4	$47.2M	Sell	117,264 -13,426	-10%	-$5.08M	0.01%	1168
2018 Q3	$53.8M	Sell	130,690 -55,961	-30%	-$19M	0.01%	1239
2018 Q2	$67.2M	Buy	186,651 +21,379	+13%	+$7.65M	0.01%	1140
2018 Q1	$53.2M	Buy	+165,272	New	+$55.6M	0.01%	1269

Other funds holding QTTB

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

ACA

Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments's QTTB Position: Q1 2026 in Review

Fidelity Investments increased its Q32 Bio (QTTB) stake by 1.1% in Q1 2026, buying an estimated $171 and bringing the position to 3,400 shares worth $21.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4476.

Fidelity Investments first reported a position in QTTB in Q1 2018 and has held it in 33 quarters since. The position peaked at $67.2M in Q2 2018. 54 funds tracked by Wall St. Rank hold QTTB as of Q1 2026.

Fidelity Investments held 3,400 shares of Q32 Bio worth $21.8K as of Q1 2026.
Fidelity Investments bought 36 Q32 Bio shares in Q1 2026, an estimated $171.
Q32 Bio made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #4476 holding.
Fidelity Investments first reported a position in Q32 Bio in Q1 2018 and has held it in 33 quarters since.
Fidelity Investments's Q32 Bio position peaked at $67.2M in Q2 2018.
54 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.